HAE
Haemonetics Corporation
Medical Devices · Healthcare · United States
119.79
close · 2026-10-29
value
43
cheaper than peers43
quality
63
stronger fundamentals63
ranked against
Medical Devices
value
quality
84 peerswide variation
Value inputs
| measure | company | vs peers |
| EV to EBITDA | 13.79× | 61 |
| forward P/E | 20.74× | 51 |
| price to sales | 2.91× | 51 |
| price to book | 6.51× | 26 |
4 of 12 measures available
Quality inputs
| measure | company | vs peers |
| operating margin | 17.9% | 90 |
| return on equity | 11.2% | 81 |
| revenue growth | 5.6% | 41 |
| debt to equity | 140.3% | 22 |
4 of 4 measures available
Facts
| market cap | $5B |
| free cash flow | $312.8M |
| employees | 3,009 |
| first trade | 1991-05-10 |
| next earnings | 2026-11-05 |
| fundamentals updated | 2026-08-10 |
Annual history
| measure | 2026 | 2025 | 2024 | 2023 |
| diluted eps | 2.05 | 3.31 | 2.29 | 2.24 |
| free cash flow | $260.4M | $142.4M | $143.6M | $81.7M |
| net income | $97.3M | $167.7M | $117.6M | $115.4M |
| revenue | $1.33B | $1.36B | $1.31B | $1.17B |
| unusual items | -$84.7M | $20.6M | -$10.4M | $382,000 |